At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 20 enrolled
Drug / intervention
Lipidem- fish oil emulsion BBraun UK +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomised Controlled Trial of the Effects of Fish Oil Emulsion in Total Parenteral Nutrition Upon Tumour Vascularity in Patients With Hepatic Colorectal Metastases
In Brief
A Phase 2 clinical trial evaluating Lipidem- fish oil emulsion BBraun UK and Digital Contrast MRI scan for Colorectal Liver Metastases. Completed, enrolled 20 participants across 1 site.
Detailed Summary
The purpose of this study is to determine whether fish oils - a known source of omega-3 given intravenously (via a 'drip') will help cure secondary deposits in the liver from bowel cancer.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsColorectal Liver Metastases
CountriesUnited Kingdom
CollaboratorsB. Braun Melsungen AG
Timeline
Phase 2CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMay 2007
First PostedJul 2009
Primary CompletionDec 2009
Study CompletionOct 2010
TodayJul 2026
First PostedJul 20, 2009
Enrollment StartMay 1, 2007
Primary CompletionDec 1, 2009
Study CompletionOct 1, 2010
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 16.9 years ago
Interventions
Lipidem- fish oil emulsion BBraun UKdietary
Digital Contrast MRI scanprocedure